Search Results 311-320 of 17311 for Bulimia

  1. Digestive Diseases Clinical Trials - Medical Professionals

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  2. Delirium - Doctors and departments - Mayo Clinic

    Learn what may cause this change in mental abilities. Symptoms develop fast and include confusion and being unaware of surroundings.

  3. Inflammatory Bowel Disease Treatment And Response To Therapy - Mayo Clinic

    The purpose of this study is to Identify baseline and early treatment genetic, molecular, and cellular drivers of 4-month endoscopic response to anti-IL-23, ...

  4. Digestive Diseases Clinical Trials - Medical Professionals

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  5. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...

  6. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  7. Mental health: Know when to get help - Mayo Clinic

    Examples of mental health conditions include anxiety, depression, eating disorders, post-traumatic stress disorder and schizophrenia. The DSM has criteria for ...

  8. Effect of Secretin on Gastric Accommodation, Emptying and Post-nutrient Challenge Symptoms in Functional Dyspepsia and Healthy Subjects - Mayo Clinic

    The purpose of this study is to compare the effects of secretin vs. saline on satiation, fasting gastric volume, gastric accommodation and emptying, and ...

  9. Publications - Elise C. Carey, M.D. - Mayo Clinic

    Palliative Care, version 1.2025 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), nccn.org. 2025. Sanders JJ, Benotti E, Jaramillo C, ...

  10. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

    Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) ...